Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > NVCT Nuvectis Pharma > Detailed Quotes

NVCT Nuvectis Pharma

Watchlist
10.375
+0.455+4.59%
Close  02/03 16:00 ET
High
10.620
Open
9.820
Turnover
1.05M
Low
9.710
Pre Close
9.920
Volume
102.48K
Market Cap
151.92M
P/E(TTM)
Loss
52wk High
20.920
Shares
14.64M
P/E(Static)
Loss
52wk Low
3.410
Float Cap
49.33M
Bid/Ask %
0.00%
Historical High
20.920
Shs Float
4.76M
Volume Ratio
0.84
Historical Low
3.080
Dividend TTM
--
Div Yield TTM
--
P/B
7.46
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
2.16%
Amplitude
9.17%
Avg Price
10.268
Lot Size
1
Float Cap
49.33M
Bid/Ask %
0.00%
Historical High
20.920
Shs Float
4.76M
Volume Ratio
0.84
Historical Low
3.080
Dividend TTM
--
P/B
7.46
Dividend LFY
--
Turnover Ratio
2.16%
Amplitude
9.17%
Avg Price
10.268
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
CEO: Mr. Ron Bentsur
Market: NASDAQ
Listing Date: 02/04/2022
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist